A new review examines how red blood cell (RBC) transfusion decisions in non-bleeding critically ill adults should move beyond reliance on haemoglobin (Hb) thresholds alone and instead incorporate a more physiologically informed, multimodal assessment of tissue oxygenation and perfusion. Although restrictive transfusion strategies are widely recommended and supported by randomised trials, the authors argue that Hb concentration alone is an imperfect surrogate for oxygen delivery and does not consistently reflect whether a patient will benefit from transfusion. As such, many transfusions are either unnecessary or administered too late, exposing patients to avoidable risks or inadequate resuscitation.
RBC transfusion practices have historically centred on numeric triggers, commonly 7–8 g/dL in stable, non-bleeding ICU patients. While these thresholds reduce exposure to blood products and associated complications, they do not account for inter-individual variability in oxygen demand, compensatory mechanisms, or microcirculatory dysfunction. The authors emphasise that anaemia tolerance varies widely depending on comorbidities, severity of illness, and organ reserve. Consequently, identical Hb values may represent adequate oxygen delivery in one patient but critical hypoxia in another.
Oxygen delivery depends not only on Hb concentration but also on cardiac output, arterial oxygen saturation, and tissue extraction capacity. Critically ill patients often develop microcirculatory impairment, mitochondrial dysfunction, and altered oxygen utilisation, which weaken the relationship between systemic Hb and actual tissue oxygenation. Therefore, correcting Hb alone may not meaningfully improve tissue perfusion or outcomes. In some cases, transfused RBCs may even worsen rheology or inflammation, further limiting benefit.
The authors propose integrating additional markers that reflect global and regional oxygen balance. Suggested parameters include lactate levels, venous oxygen saturation, indicators of cardiac output and perfusion, and microcirculatory assessments. These measures may help identify physiological triggers of inadequate oxygen delivery, enabling clinicians to tailor transfusion decisions to patient-specific needs rather than rigid thresholds. Such a strategy aligns with precision medicine principles and aims to deliver transfusions only when a meaningful physiological benefit is likely.
The review presents a conceptual decision-making algorithm that combines Hb values with clinical and physiological signs. Rather than acting solely on an Hb number, clinicians are encouraged to first evaluate haemodynamic stability, evidence of tissue hypoxia, and the adequacy of compensatory mechanisms. If signs of impaired perfusion or oxygen debt are present, transfusion may be justified even at relatively higher Hb levels. In stable patients without evidence of hypoxia, transfusion can often be deferred despite low Hb. This framework promotes a stepwise, multimodal evaluation and discourages automatic transfusion practices.
Implementing this approach requires reliable monitoring tools and careful interpretation. Many physiological markers have limitations, including variability, invasiveness, or lack of standardised thresholds. Moreover, the evidence linking specific parameters to improved transfusion outcomes remains incomplete. The proposed strategy should complement, rather than replace, current restrictive guidelines until stronger data emerge.
Further research is needed to validate physiological triggers and multimodal transfusion strategies. Prospective studies should investigate whether integrating measures of tissue oxygenation, perfusion, and microcirculatory function improves patient-centred outcomes compared with Hb-based thresholds alone. Standardisation of monitoring techniques and clearer definitions of actionable parameters are also needed. Ultimately, the goal is to refine transfusion practice to maximise benefit while minimising harm.
Overall, the authors advocate a shift from purely Hb-driven transfusion triggers towards a comprehensive, physiology-guided approach in non-bleeding critically ill patients. By incorporating multiple indicators of oxygen delivery and tissue need, clinicians may better identify who truly benefits from RBC transfusion. This patient-centred, multimodal framework seeks to improve decision-making, reduce unnecessary transfusions, and enhance outcomes in the ICU setting.
Source: Intensive Care Medicine
Image Credit: iStock
